New Investigator Award
New Investigator Award supports new academic scientists developing translational Angelman syndrome research and technologies to advance treatment approaches and establish lasting research programs.
Browse similar grants
Funder: Foundation for Angelman Syndrome Therapeutics (FAST)
Due Dates: Rolling (LOIs and applications; no fixed deadline)
Funding Amounts: Recommended maximum $150,000 per year for one or two years, allocated annually
Summary: Supports new academic investigators establishing translational Angelman syndrome research programs or developing technologies that advance treatment approaches.
Key Information: Applicants must be new primary investigators within their first five years of an academic position.
Description
The Foundation for Angelman Syndrome Therapeutics (FAST) offers this award to expand the pool of researchers studying Angelman syndrome and help promising new scientists establish significant research programs. It supports translational research and technologies specifically relevant to advancing Angelman syndrome treatment modalities. Funded work is expected to generate data for future grants and publications.
FAST prioritizes projects with potential for immediate, high impact on the Angelman community, particularly research translating biomedical knowledge into clinical applications. Its broader research priorities include translational and clinical research as well as high-risk, high-reward discovery projects. Expedited project timelines are encouraged, with support tailored to the proposed scope of work.
